ArticleMolecular genetics and metabolism reports2021

Nonclinical safety evaluation of pabinafusp alfa, an anti-human transferrin receptor antibody and iduronate-2-sulfatase fusion protein, for the treatment of neuronopathic mucopolysaccharidosis type II.

Ryuji Yamamoto et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.